Hypertension and Cardiovascular Disease and Its Management
作者： José A. García-Donaire , Luis M. Ruilope
DOI: 10.1002/9781118337967.CH6
关键词:
摘要:
sci-hub.st 参考文章(74)
UK Prospective Diabetes Study Group, None, Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ. ,vol. 317, pp. 703- 713 ,(1998)
Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. The Lancet. ,vol. 360, pp. 1903- 1913 ,(2002) , 10.1016/S0140-6736(02)11911-8
Effects of intensive glucose lowering in type 2 diabetes The New England Journal of Medicine. ,vol. 358, pp. 2545- 2559 ,(2008) , 10.1056/NEJMOA0802743
Effects of an angiotensin-converting -enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients The New England Journal of Medicine. ,vol. 342, pp. 145- 153 ,(2000) , 10.1056/NEJM200001203420301
Salim Yusuf, MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial. Commentary The Lancet. ,vol. 360, pp. 7- 22 ,(2002)
, Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials The Lancet. ,vol. 362, pp. 1527- 1535 ,(2003) , 10.1016/S0140-6736(03)14739-3
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack The Lancet. ,vol. 358, pp. 1033- 1041 ,(2001) , 10.1016/S0140-6736(01)06178-5
R. W. Schrier, R. O. Estacio, B. Jeffers, Appropriate Blood Pressure Control in NIDDM (ABCD) Trial Diabetologia. ,vol. 39, pp. 1646- 1654 ,(1996) , 10.1007/S001250050629
L LEITER, R LEWANCZUK, Of the renin-angiotensin system and reactive oxygen species: Type 2 diabetes and angiotensin II inhibition American Journal of Hypertension. ,vol. 18, pp. 121- 128 ,(2005) , 10.1016/J.AMJHYPER.2004.07.001
MD Carl J. Pepine, PhD Eileen M. Handberg, PharmD Rhonda M. Cooper-DeHoff, PhD Ronald G. Marks, MD Peter Kowey, MD Franz H. Messerli, MD Giuseppe Mancia, MD José L. Cangiano, MD David Garcia-Barreto, MD Matyas Keltai, MD Serap Erdine, MS Heather A. Bristol, RN H. Robert Kolb, MD George L. Bakris, MD Jerome D. Cohen, MD William W. Parmley, for the INVEST Investigators, None, A Calcium Antagonist vs a Non–Calcium Antagonist Hypertension Treatment Strategy for Patients With Coronary Artery Disease JAMA. ,vol. 290, pp. 2805- 2816 ,(2003) , 10.1001/JAMA.290.21.2805